Latham & Watkins Advises Enko Chem in its US$45 Million Series B Financing

A Boston-based team represented the crop protection company in the transaction.

June 26, 2020

Enko Chem, Inc. has publicly launched after securing US$45 million in a Series B round of financing, bringing its total funding raised to date to US$66 million. Led by the Bill & Melinda Gates Foundation, the latest round attracted a strong mix of existing (Anterra Capital and Rabobank) and new (Finistere Ventures, Novalis LifeSciences, Germin8 Ventures, TO Ventures Food) investors. 

Latham & Watkins LLP represented Enko Chem, Inc. in the financing with a Boston-based corporate team led by partner Kristen Grannis, with associates Spencer Ricks, Peter Prial, and Tyler Mills.
 

 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.